Lycia Therapeutics

Developer of protein degradation drugs for the treatment of cancer and auto-immune disease

placeSan Francisco, California, United States calendar_todayFounded 2020 groups22 employees language lyciatx.com

Registered entities

Social engagement

Social engagement: 6.7K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Versant Ventures, Venrock.

Investor typeCountShare
Venture capital330%
Private equity110%
Other / undisclosed660%

Hiring activity

Hires occasionally

2 roles tracked across 1 of the last 12 months

31 Jan 2026 · Associate Director/Director, Clinical Science · South San Francisco

Based on job postings tracked across public sources.

Recent activity

25 Jun 2026
Leadership hire
Chief Financial Officer
Coming soon